Business · 17/07/2013

FDA Authorizes Emergency Use of In Vitro Diagnostic for MERS-CoV Detection

The US Food and Drug Administration (FDA) has issued an Emergency Use Authorization (EUA) for an in vitro diagnostic device to detect Middle East Respiratory Syndrome Coronavirus (MERS-CoV), following a determination by the Secretary of Health and Human Services that there is a significant public health emergency.